drugset / Trial / NCT05586763

Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.

NCT05586763

Phase 3 Unknown 90 enrolled Oman Medical Speciality Board
RandomizedParallel-groupTriple-blindTreatment

Summary

Background: Vertigo as acute symptom seem to be one of most common presentation in ED, can be treated in ED with multiple medication . Objective: This study aimed to compare the therapeutic efficacy of metoclopramide, promethazine and prochloroperazine in patients presenting with signs and symptoms suggestive of acute peripheral vertigo to the ED . Methods: A 3-arm multi-center, randomized, triple-blind, controlled study comparing three treatments for acute vertigo in three medical centers : AlNahdha hospital Oman , Sohar Hospital Oman and AFH hospital Oman. Oman From February 2022 to August 2024.

Timeline

Start
2022-02-01
Primary completion
2024-12-28
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg Intramuscular
Comparator Prochloroperazine Unknown 12.5 mg Intramuscular
Comparator Promethazine Small molecule 25 mg Intramuscular

Indications